Literature DB >> 16716307

In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE).

Filipe Almeida Monteiro1, Isabel Cardoso, Mónica Mendes Sousa, Maria João Saraiva.   

Abstract

Familial amyloidotic polyneuropathy is a neurodegenerative disorder characterized by systemic extracellular deposition of transthyretin (TTR) amyloid fibrils. The latter have been proposed to trigger neurodegeneration through engagement of the receptor for advanced glycation end products (RAGE). Here we show that TTR interaction with RAGE is conserved across mouse and human species and is not dependent on RAGE glycosylation. Moreover, strand D of TTR structure seems important for the TTR-RAGE interaction as well as a motif in RAGE (residues 102-118) located within the V-domain; this motif suppressed TTR aggregate-induced cytotoxicity in cell culture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716307     DOI: 10.1016/j.febslet.2006.05.020

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Solution structure of the soluble receptor for advanced glycation end products (sRAGE).

Authors:  Zsuzsa Sárkány; Teemu P Ikonen; Frederico Ferreira-da-Silva; Maria João Saraiva; Dmitri Svergun; Ana Margarida Damas
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

2.  Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.

Authors:  Yukio Akasaki; Natàlia Reixach; Tokio Matsuzaki; Oscar Alvarez-Garcia; Merissa Olmer; Yukihide Iwamoto; Joel N Buxbaum; Martin K Lotz
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

3.  The Amphipathic GM1 Molecule Stabilizes Amyloid Aggregates, Preventing their Cytotoxicity.

Authors:  Monica Bucciantini; Manuela Leri; Massimo Stefani; Ronald Melki; Sandra Zecchi-Orlandini; Daniele Nosi
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

Review 4.  The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.

Authors:  Andisheh Abedini; Julia Derk; Ann Marie Schmidt
Journal:  Protein Sci       Date:  2018-07       Impact factor: 6.725

5.  Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.

Authors:  C Brorsson; N T Hansen; K Lage; R Bergholdt; S Brunak; F Pociot
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

6.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21

Review 7.  Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Biochem Pharmacol       Date:  2010-01-22       Impact factor: 5.858

8.  Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.

Authors:  Maike F Dohrn; Christoph Röcken; Jan L De Bleecker; Jean-Jacques Martin; Matthias Vorgerd; Peter Y Van den Bergh; Andreas Ferbert; Katrin Hinderhofer; J Michael Schröder; Joachim Weis; Jörg B Schulz; Kristl G Claeys
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

Review 9.  Is RAGE still a therapeutic target for Alzheimer's disease?

Authors:  Richard J Deane
Journal:  Future Med Chem       Date:  2012-05       Impact factor: 3.808

10.  The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.

Authors:  João Moreira; Susete Costelha; Margarida Saraiva; Maria João Saraiva
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.